| Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia L Fellner, R Irschick, K Schanda, M Reindl, L Klimaschewski, W Poewe, ... Glia 61 (3), 349-360, 2013 | 661 | 2013 |
| Toll-like receptor 4 promotes α-synuclein clearance and survival of nigral dopaminergic neurons N Stefanova, L Fellner, M Reindl, E Masliah, W Poewe, GK Wenning The American journal of pathology 179 (2), 954-963, 2011 | 277 | 2011 |
| Glia and alpha-synuclein in neurodegeneration: A complex interaction D Brück, GK Wenning, N Stefanova, L Fellner Neurobiology of disease 85, 262-274, 2016 | 198 | 2016 |
| Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts L Fellner, KA Jellinger, GK Wenning, N Stefanova Acta neuropathologica 121, 675-693, 2011 | 184 | 2011 |
| The role of glia in alpha-synucleinopathies L Fellner, N Stefanova Molecular neurobiology 47, 575-586, 2013 | 74 | 2013 |
| Anle138b partly ameliorates motor deficits despite failure of neuroprotection in a model of advanced multiple system atrophy L Fellner, D Kuzdas-Wood, J Levin, S Ryazanov, A Leonov, C Griesinger, ... Frontiers in neuroscience 10, 99, 2016 | 28 | 2016 |
| Neuroprotection by epigenetic modulation in a transgenic model of multiple system atrophy E Sturm, L Fellner, F Krismer, W Poewe, GK Wenning, N Stefanova Neurotherapeutics 13 (4), 871-879, 2016 | 20 | 2016 |
| Models of multiple system atrophy L Fellner, GK Wenning, N Stefanova Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease, 369-393, 2015 | 19 | 2015 |
| Emergent creativity in frontotemporal dementia F Geser, KA Jellinger, L Fellner, GK Wenning, D Yilmazer-Hanke, ... Journal of Neural Transmission 128, 279-293, 2021 | 18 | 2021 |
| Autophagy in α-synucleinopathies—An overstrained system L Fellner, E Gabassi, J Haybaeck, F Edenhofer Cells 10 (11), 3143, 2021 | 16 | 2021 |
| Limited effects of dysfunctional macroautophagy on the accumulation of extracellularly derived α-synuclein in oligodendroglia: implications for MSA pathogenesis L Fellner, E Buchinger, D Brueck, R Irschick, GK Wenning, N Stefanova BMC neuroscience 19, 1-14, 2018 | 12 | 2018 |
| Development of neurodegeneration in amyotrophic lateral sclerosis: from up or down? F Geser, L Fellner, J Haybaeck, GK Wenning Journal of Neural Transmission 127, 1097-1105, 2020 | 7 | 2020 |
| Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity D Kuzdas-Wood, L Fellner, M Premstaller, C Borm, B Bloem, D Kirik, ... BMC neuroscience 16, 1-10, 2015 | 6 | 2015 |
| Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models A Spathopoulou, F Edenhofer, L Fellner Frontiers in Neurology 12, 786835, 2022 | 3 | 2022 |
| Guanosine protects neuronal PC12 cells from serum deprivation-induced cell death B Thauerer, BE Baeumer, L Fellner, D Kuzdas, M Ramberger, ... Pteridines 23 (1), 27-32, 2012 | 2 | 2012 |
| Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy L Fellner, F Richter, P Brundin, J Haybaeck Frontiers in neurology 13, 942313, 2022 | 1 | 2022 |
| Commentary: Discriminating α-synuclein strains in parkinson's disease and multiple system atrophy L Fellner, KA Jellinger, GK Wenning, J Haybaeck Frontiers in Neuroscience 14, 565863, 2020 | 1 | 2020 |
| Multiple system atrophy–Are cerebrospinal fluid cytokines reliable potential diagnostic marker? L Fellner, GK Wenning Parkinsonism & Related Disorders 65, 1-2, 2019 | 1 | 2019 |
| Disturbance of innate immunity linked to toll-like receptor 4 promotes neurodegeneration in a transgenic alpha-synucleinopathy model N Stefanova, S Stemberger, L Fellner, P Fuchs, M Hainzer, M Reindl, ... MOVEMENT DISORDERS 25 (7), S210-S211, 2010 | 1 | 2010 |
| Generation of the human induced pluripotent stem cell line (IBKMOLi003-A) from PBMCs of a vascular Ehlers-Danlos syndrome (vEDS) patient carrying the heterozygous nonsense … S Höpperger, A Spathopoulou, L Mayer-Suess, M Suarez-Cubero, ... Stem Cell Research 75, 103321, 2024 | | 2024 |
Gregor K. WenningChair Division of Clinical Neurobiology, Medical University of InnsbruckBestätigte E-Mail-Adresse bei i-med.ac.at
